Video PlayerClose TOKYO, Dec. 3 (Xinhua) — Tokyo stocks closed slightly higher Thursday, driven by hopes for normalized economic activity due to COVID-19 vaccine development and expectations that U.S. stimulus talks will resume after being stalled for months. The 225-issue Nikkei Stock Average increased 8.39 points, or 0.03 percent, from Wednesday at 26,809.37. The broader Topix index of all First Section issues on the Tokyo Stock Exchange, meanwhile, gained 1.28 points, or 0.07 percent, to finish at 1,775.25. Marine and air transportation and pulp and paper issues comprised those that gained the most by the close of play. Throughout the day, the U.S. dollar remained steady in the mid-104 yen range, boosted by improved risk appetite following Britain’s approval of a COVID-19 vaccine developed by U.S. pharmaceutical giant Pfizer Inc. and German partner BioNTech SE, said some dealers. After moving narrowly around Wednesday’s closing level, the Nikkei entered into positive territory. The market saw buying in shares perceived undervalued due to the coronavirus outbreak offset by selling to lock in profits, brokers said. “With good news and bad news mixed, such as signs of U.S. lawmakers restarting negotiations on a stimulus package and stay-at-home orders issued in Los Angeles, investors… Read full this story
- Morning Digest: India close to approving COVID-19 vaccine; fiscal deficit shoots up to 135% of Budget target, and more
- Roundup: Tokyo stocks end sharply higher on U.S. stimulus expectations
- Tokyo stocks close sharply higher on U.S. stimulus expectations
- Tokyo stocks close sharply higher as hopes for stimulus lift Wall Street
- Bay Area COVID Roundup: Thanksgiving Surge Takes Deadly Toll; COVID-19 Vaccine Lottery Proposal; State Health Officials Urge 10-Day Travel Quarantine
- Roundup: Egypt licenses China's Sinopharm COVID-19 vaccine for emergency use; Israel reports 7 more cases of new coronavirus strain
- COVID-19 vaccination: France aims to make up for lost time
- ‘Best is Yet to Come’: Trump Delivers End of 2020 Speech Praising COVID-19 Vaccine Effort
- CDSCO expert panel recommends approval of Oxford COVID-19 vaccine Covishield for emergency use in India
- On COVID-19 vaccine, why India could catch up quickly
Roundup: Tokyo stocks close slightly higher on COVID-19 vaccine hopes have 331 words, post on www.xinhuanet.com at December 3, 2020. This is cached page on Europe Breaking News. If you want remove this page, please contact us.